3 recruiting, 2 completed, 1 active not recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Recruiting 1 |
Follow Qian Chu: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Durvalumab as Consolidation for Patients LS-SCLC Induction Durvalumab +etoposide/platinum +Radiochemotherapy+ durvalumab maintenance - Small Cell Lung Cancer Limited Stage | Phase 2 | Recruiting | Qian Chu | 100 | 2026-02-24 | 2026-03-27 |
| Prediction of Outcome to Neoadjuvant Therapy in Non-small Cell Lung Cancer（NSCLC） NSCLC, Neoadjuvant Therapy | Recruiting | Qian Chu | 500 | 2025-12-01 | 2026-03-19 | |
| Symptoms Burden in Lung Cancer Patients Undergoing Definitive Chemoradiotherapy: Insights From Electronic Patient-Reported Outcomes Electronic Patient-Reported Outcome Monitoring - Lung Cancer, Chemoradiotherapy | Recruiting | Qian Chu | 100 | 2024-06-01 | 2025-08-20 | |
| Cadonilimab (AK104) Plus Chemotherapy as First-line Treatment in Non-squamous Non-Small Cell Lung Cancer (NSCLC) Patients With Programmed Cell Death Ligand 1 (PD-L1) Negative Cadonilimab, Pemetrexed, Carboplatin - Carcinoma, Non-Small-Cell Lung | Phase 2 | Active not recruiting | Qian Chu | 49 | 2023-08-07 | 2026-10-16 |
| Camrelizumab Plus Famitinib as Treatment in Patient With Advanced or Metastatic Pulmonary Sarcomatoid Carcinoma Camrelizumab, Famitinib - Sarcomatoid Carcinoma of Lung | Phase 2 | Completed | Qian Chu | 17 | 2021-07-19 | 2026-10-14 |
| A Real-world Study: Efficacy and Safety of Anlotinib for Advanced Non-small Cell Lung Cancer(NSCLC) NSCLC | Completed | Qian Chu | 373 | 2019-07-12 | 2022-10-21 |
Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1) · Small Cell Lung Carcinoma (1) · Syndrome (1)
Carboplatin (1) · Pemetrexed (1) · camrelizumab (1) · famitinib (1)
China (6)
Fengjun Cao (1) · Guangqiao Qu (1) · Guiming Chen (1) · Jun Li (1) · Li Kuang (1) · Lin Wu (1) · Ruizhi Ran (1) · Tienan Yi (1) · Xinhua Xu (1) · Yang Fu (1) · Yanhua Xu (1) · Yifa Yin (1) · Yinping Li (1) · Youhong Dong (1)